Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial (vol 6, e2325332, 2023)

被引:0
|
作者
Garcia-Pardo, M.
Czarnecka-Kujawa, K.
Law, J. H.
机构
关键词
D O I
10.1001/jamanetworkopen.2025.1147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 3 条
  • [1] Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial
    Garcia-Pardo, Miguel
    Czarnecka-Kujawa, Kasia
    Law, Jennifer H.
    Salvarrey, Alexandra M.
    Fernandes, Roxanne
    Fan, Zhen J.
    Waddell, Thomas K.
    Yasufuku, Kazuhiro
    Liu, Geoffrey
    Donahoe, Laura L.
    Pierre, Andrew
    Le, Lisa W.
    Gunasegaran, Tharsiga
    Ghumman, Noor
    Shepherd, Frances A.
    Bradbury, Penelope A.
    Sacher, Adrian G.
    Schmid, Sabine
    Corke, Lucy
    Feng, Jamie
    Stockley, Tracy
    Pal, Prodipto
    Rogalla, Patrik
    Pipinikas, Christodoulos
    Howarth, Karen
    Ambasager, Bana
    Mezquita, Laura
    Tsao, Ming S.
    Leighl, Natasha B.
    JAMA NETWORK OPEN, 2023, 6 (07) : e2325332
  • [2] Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing A Phase 2 Nonrandomized Clinical Trial
    Xu, Jiachen
    Liu, Zheng
    Bai, Hua
    Dong, Guilan
    Zhong, Jia
    Wan, Rui
    Zang, Aiming
    Li, Xiaoling
    Li, Qingshan
    Guo, Jun
    Du, Nan
    Zhong, Diansheng
    Huang, Yan
    Lv, Qun
    Zhang, Jinghua
    Zhao, Yue
    Gao, Liming
    Li, Lin
    Zhang, Chunyi
    Zhao, Jun
    Li, Baolan
    Liu, Zhe
    Yang, Zhenlin
    Ji, Dong
    Wang, Tao
    Duan, Jianchun
    Wang, Zhijie
    Wang, Jie
    JAMA ONCOLOGY, 2022, 8 (09) : 1328 - 1332
  • [3] Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial (vol 6, pg 681, 2018)
    Wang, Z.
    Cheng, Y.
    An, T.
    LANCET RESPIRATORY MEDICINE, 2018, 6 (09): : E50 - E50